INSM Insmed Incorporated - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 6, 2026 10-K/10-Q Aug 6, 2026
$105,23
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$90,3952-Wochen-Tief
$212,7552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$22.97B
P/E (TTM)
-25.5
EPS (TTM)
$-4.12
Umsatz (TTM)
$1.14B
Ihre Abzeichen
52W-Spanne
$90–$213
Analystenbewertung
BUY
Kursziel
$198
P/E
-25.5
ROE
-87.2%
Nettogewinnmarge
-76.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
INSM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$105.23
Marktkapitalisierung (MRQ)
$22.97B
P/E (TTM)
-25.5
EPS (TTM)
$-4.12
Umsatz (TTM)
$1.14B
ROE (TTM)
-87.2%
Verschuldungsgrad (MRQ)
0.7
52W-Spanne
$90–$213
INSM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 3. März 2011 | 1-for-10 | Umgekehrt |
| 31. Juli 2000 | 1-for-4 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$606M2016-12-31 → 2025-12-31
EPS$-6.422019-12-31 → 2025-12-31
Freier Cashflow$-968M2016-12-31 → 2025-12-31
Nettogewinnmarge-76.9%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | INSM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -25.55-Jahres-Durchschnitt ≈-11.5 | ≈-11.5 | · | · | |
| P/S (TTM) | 20.25-Jahres-Durchschnitt ≈27.8 | ≈27.8 | 6.4 | Überbewertet | |
| K/B (MRQ) | 30.35-Jahres-Durchschnitt ≈23.7 | ≈23.7 | 6.1 | Überbewertet | |
| EV / EBITDA | -17.65-Jahres-Durchschnitt ≈-12.9 | ≈-12.9 | · | · | |
| Kurs / FCF (TTM) | -28.45-Jahres-Durchschnitt ≈-16.0 | ≈-16.0 | · | · | |
| Kurs / Cashflow (TTM) | -29.55-Jahres-Durchschnitt ≈-16.4 | ≈-16.4 | · | · | |
| EV / Umsatz (TTM) | 19.65-Jahres-Durchschnitt ≈27.3 | ≈27.3 | · | · | |
| EV / FCF (TTM) | -27.75-Jahres-Durchschnitt ≈-15.7 | ≈-15.7 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 34.65-Jahres-Durchschnitt ≈75.5 | ≈75.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | INSM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -73.9%5-Jahres-Durchschnitt ≈-213.0% | ≈-213.0% | 17.9% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -205.6%5-Jahres-Durchschnitt ≈-211.2% | ≈-211.2% | 16.9% | Schwach | |
| Vorgewinnmarge (TTM) | -76.4%5-Jahres-Durchschnitt ≈-226.4% | ≈-226.4% | 13.8% | Schwach | |
| Nettogewinnmarge (TTM) | -76.9%5-Jahres-Durchschnitt ≈-226.9% | ≈-226.9% | 13.9% | Schwach | |
| ROA (TTM) | -38.2%5-Jahres-Durchschnitt ≈-48.0% | ≈-48.0% | 6.8% | Schwach | |
| ROE (TTM) | -87.2%5-Jahres-Durchschnitt ≈-376.1% | ≈-376.1% | 18.7% | Schwach | |
| ROIC | -97.8%5-Jahres-Durchschnitt ≈-64.8% | ≈-64.8% | 19.5% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | INSM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.75-Jahres-Durchschnitt ≈3.1 | ≈3.1 | 0.0 | Hohe Verschuldung | |
| Liquiditätsgrad (MRQ) | 3.75-Jahres-Durchschnitt ≈5.3 | ≈5.3 | 3.5 | Im Einklang | |
| Quick Ratio (MRQ) | 3.15-Jahres-Durchschnitt ≈4.7 | ≈4.7 | 3.0 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.75-Jahres-Durchschnitt ≈3.1 | ≈3.1 | · | · | |
| Interest Coverage (Zinsdeckungsgrad) | -14.95-Jahres-Durchschnitt ≈-12.1 | ≈-12.1 | 8.8 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | INSM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 66.7%5-Jahres-Durchschnitt ≈31.0% | ≈31.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 35.2%5-Jahres-Durchschnitt ≈27.5% | ≈27.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 29.8% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | INSM | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.35-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.5 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 1.15-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 1.9 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 6.35-Jahres-Durchschnitt ≈8.2 | ≈8.2 | 6.6 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$364.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
6.1%
Nächster Bericht
Okt 28, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $-0.06 | $-0.80 | 92.5% |
| 31. März 2026 | Mai 6, 2026 | $-0.76 | $-0.98 | 22.3% |
| 31. Dezember 2025 | $-1.54 | $-1.32 | -17.0% | |
| 30. September 2025 | $-1.75 | $-1.37 | -28.1% | |
| 30. Juni 2025 | $-1.70 | $-1.32 | -28.9% | |
| 31. März 2025 | $-1.42 | $-1.36 | -4.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | · | |
| Cost of Revenue | $123M | $86M | $66M | $55M | $44M | $40M | $24M | $2M | $0 | $0 | · | · | |
| Gross Profit | · | · | · | · | · | · | $112M | $7M | $0 | · | · | · | |
| R&D Expense | $771M | $598M | $571M | $398M | $273M | $181M | $132M | $145M | $110M | $123M | $74M | $56M | |
| SG&A Expense | $701M | $461M | $345M | $266M | $234M | $204M | $211M | $168M | $79M | $51M | $43M | $31M | |
| Operating Expenses | $1.85B | $1.24B | $1.01B | $703M | $564M | $430M | $372M | $317M | $189M | $173M | $117M | $87M | |
| Operating Income | $-1.25B | $-878M | $-710M | $-457M | $-375M | $-265M | $-235M | $-307M | $-189M | $-173M | $-117M | $-87M | |
| Interest Expense | $84M | $85M | $82M | $26M | $40M | $30M | $28M | $25M | $6M | $3M | $3M | $2M | |
| Other Non-op | $-2M | $29.0K | $2M | $-6M | $-3M | $405.0K | $-531.0K | $602.0K | $300.0K | $119.0K | $-33.0K | $141.0K | |
| Pretax Income | $-1.27B | $-910M | $-747M | $-480M | $-436M | $-293M | $-254M | $-324M | $-193M | $-176M | $-120M | $-90M | |
| Income Tax | $5M | $4M | $3M | $1M | $-2M | $1M | $777.0K | $201.0K | $-272.0K | $98.0K | $-2M | $-10M | |
| Net Income | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| EPS (Basic) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| EPS (Diluted) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · | |
| Shares (Basic) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| Shares (Diluted) | 199,014,000 | 164,043,000 | 140,433,000 | 123,035,000 | 112,111,000 | 97,605,000 | 84,560,000 | 76,889,000 | 66,576,000 | 61,892,000 | 58,633,000 | 43,095,000 | |
| EBITDA | $-1.25B | $-878M | $-704M | $-452M | $-366M | $-256M | $-230M | $-304M | $-186M | $-171M | $-116M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $510M | $555M | $482M | $1.07B | $717M | $533M | $487M | $495M | $381M | $163M | $283M | $159M | |
| Short-term Investments | $920M | $879M | $298M | $74M | $0 | · | · | · | · | · | · | · | |
| Receivables | $141M | $52M | $41M | $30M | $24M | $17M | $19M | $6M | $0 | · | · | · | |
| Inventory | $132M | $99M | $83M | $70M | $67M | $50M | $28M | $7M | $0 | · | · | · | |
| Prepaid Expense | $91M | $37M | $24M | $25M | $29M | $24M | $20M | $11M | $8M | $6M | $5M | $5M | |
| Current Assets | $1.79B | $1.62B | $929M | $1.27B | $837M | $623M | $555M | $519M | $389M | $168M | $288M | $165M | |
| PP&E (Net) | $103M | $80M | $65M | $56M | $53M | $54M | $60M | $23M | $12M | $10M | $8M | $8M | |
| PP&E (Gross) | $164M | $130M | $110M | $96M | $90M | $82M | $79M | $37M | $23M | $18M | $13M | $11M | |
| Accum. Depreciation | $61M | $50M | $45M | $39M | $37M | $28M | $19M | $14M | $11M | $8M | $5M | $3M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $0 | · | · | · | · | · | · | |
| Intangibles | $98M | $59M | $64M | $69M | $74M | $49M | $54M | $59M | $58M | · | · | · | |
| Total Assets | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Accounts Payable | $80M | $73M | $65M | $50M | $36M | $43M | $13M | $18M | $15M | $10M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | $61M | $38M | $40M | $38M | $17M | $17M | $11M | $10M | |
| Current Liabilities | $469M | $298M | $226M | $190M | $135M | $119M | $85M | $80M | $45M | $28M | $22M | $20M | |
| Capital Leases | $12M | $9M | $11M | $15M | $21M | $21M | $29M | · | · | · | · | · | |
| Other Non-current Liabilities | $6M | $499.0K | $3M | $9M | $20M | $9M | $11M | $0 | $765.0K | $693.0K | $572.0K | $23.0K | |
| Total Liabilities | $1.53B | $1.74B | $1.66B | $1.57B | $833M | $520M | $481M | $396M | $101M | $83M | $45M | $45M | |
| Long-term Debt | $547M | $1.12B | $1.18B | $1.15B | $800M | $450M | $450M | $450M | $55M | $55M | $25M | $25M | |
| Total Debt | $541M | $1.10B | $1.16B | $1.13B | $567M | $356M | $336M | $317M | $56M | $55M | $25M | · | |
| Common Stock | $2M | $2M | $1M | $1M | $1M | $1M | $897.0K | $773.0K | $766.0K | $620.0K | $618.0K | $498.0K | |
| Paid-in Capital | $6.37B | $4.65B | $3.11B | $2.78B | $2.67B | $2.11B | $1.80B | $1.49B | $1.32B | $919M | $900M | $657M | |
| Retained Earnings | $-5.64B | $-4.36B | $-3.45B | $-2.70B | $-2.27B | $-1.83B | $-1.54B | $-1.28B | $-958M | $-765M | $-589M | $-471M | |
| AOCI | $1M | $-2M | $-745.0K | $756.0K | $968.0K | $193.0K | $-10.0K | $-9.0K | $-3.0K | $-65.0K | · | · | |
| Stockholders' Equity | $739M | $285M | $-332M | $88M | $410M | $276M | $262M | $208M | $361M | $154M | $312M | $186M | |
| Liabilities + Equity | $2.26B | $2.03B | $1.33B | $1.66B | $1.24B | $796M | $742M | $605M | $462M | $238M | $357M | $231M | |
| Shares Outstanding | 214,255,853 | 179,383,000 | 147,978,000 | 135,654,000 | 118,738,000 | 102,763,060 | 89,682,387 | 77,307,521 | 76,610,508 | 62,019,889 | 61,813,995 | 49,806,131 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $6M | $5M | $9M | $9M | $5M | $4M | $3M | $2M | $2M | $1M | |
| Stock-based Comp | $153M | $97M | $75M | $58M | $46M | $36M | $27M | $26M | $18M | $18M | $16M | $11M | |
| Deferred Tax | $-27.0K | $-29.0K | $-54.0K | $-231.0K | $-3M | $0 | $0 | $0 | $-417.0K | $0 | $0 | · | |
| Amort. of Intangibles | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $1M | $0 | $0 | · | · | |
| Other Non-cash | · | · | $133M | $18M | $20M | $29M | $-28M | $36M | $12M | $9M | $-89.0K | · | |
| Operating Cash Flow | $-935M | $-684M | $-536M | $-400M | $-363M | $-219M | $-251M | $-258M | $-160M | $-147M | $-101M | $-64M | |
| CapEx | $33M | $22M | $13M | $10M | $7M | $6M | $42M | $13M | $3M | $4M | $3M | $5M | |
| Investing Cash Flow | $-65M | $-583M | $-224M | $-35M | $-64M | $-7M | $-42M | $-15M | $-3M | $-4M | $-3M | · | |
| Stock Issued | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | $0 | $223M | $109M | |
| Net Stock Activity | $823M | $1.08B | $152M | $292M | $270M | $246M | $261M | $0 | $378M | · | $223M | · | |
| Financing Cash Flow | $954M | $1.34B | $168M | $793M | $613M | $271M | $285M | $387M | $381M | $31M | $228M | · | |
| Net Change in Cash | $-45M | $73M | $-592M | $357M | $184M | $45M | $-8M | $114M | $219M | $-120M | $124M | $45M | |
| Taxes Paid | $4M | $2M | $2M | $2M | $2M | $814.0K | $339.0K | $154.0K | $166.0K | $85.0K | $-3M | $9M | |
| Free Cash Flow | $-968M | $-706M | $-550M | $-410M | $-371M | $-226M | $-293M | $-271M | $-163M | $-151M | $-104M | · | |
| Levered FCF | $-1.05B | $-791M | $-632M | $-437M | $-411M | $-255M | $-321M | $-297M | $-169M | $-154M | $-107M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 82.3% | · | · | · | · | · | |
| Operating Margin | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% | -161.3% | -172.4% | -3124.9% | · | · | · | · | |
| Net Margin | -210.5% | -251.2% | -245.6% | -196.3% | -230.6% | -178.9% | -186.4% | -3297.2% | · | · | · | · | |
| Pretax Margin | -209.7% | -250.2% | -244.8% | -195.7% | -231.6% | -178.0% | -185.8% | -3295.1% | · | · | · | · | |
| EBITDA Margin | -205.6% | -241.5% | -230.7% | -184.2% | -194.2% | -155.8% | -168.6% | -3088.3% | · | · | · | · | |
| ROA | -59.5% | -54.5% | -50.2% | -33.2% | -42.6% | -38.2% | -37.8% | -60.8% | -55.0% | -59.3% | -40.2% | · | |
| ROE | -128.4% | -237.7% | 241.3% | -1660.7% | -95.0% | -92.9% | -89.9% | -129.8% | -74.7% | -75.6% | -47.5% | · | |
| ROIC | -97.8% | -63.5% | -86.5% | -37.8% | -38.2% | -42.1% | -39.5% | -58.6% | -45.3% | -82.9% | -34.3% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 | 5.2 | 6.5 | 6.5 | 8.7 | 6.0 | 12.9 | · | |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 | 4.6 | 5.9 | 6.3 | 8.5 | 5.8 | 12.7 | · | |
| Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| LT Debt / Equity | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 | 1.3 | 1.3 | 1.5 | 0.2 | 0.4 | 0.1 | · | |
| Interest Coverage | -14.9 | -10.3 | -8.7 | -17.3 | -9.3 | -9.0 | -8.5 | -12.1 | -31.9 | -49.6 | -40.7 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.0 | 0.0 | · | · | · | |
| Inventory Turnover | 1.1 | 0.9 | 0.9 | 0.8 | 0.8 | 1.0 | 1.4 | 0.7 | · | · | · | · | |
| Receivables Turnover | 6.3 | 7.8 | 8.6 | 9.1 | 9.2 | 9.2 | 11.0 | 3.6 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.45 | $1.59 | $-2.24 | $0.65 | $3.46 | $2.68 | $2.92 | $2.69 | $4.71 | $2.49 | $5.04 | · | |
| Revenue / Share | $3.05 | $2.22 | $2.17 | $1.99 | $1.68 | $1.68 | $1.61 | $0.13 | $0.00 | · | · | · | |
| Cash Flow / Share | $-4.70 | $-4.17 | $-3.82 | $-3.25 | $-3.24 | $-2.25 | $-2.96 | $-3.36 | $-2.40 | $-2.37 | $-1.72 | · | |
| Cash / Share | $2.38 | $3.09 | $3.26 | $7.92 | $6.04 | $5.18 | $5.44 | $6.40 | $4.98 | $2.62 | $4.58 | · | |
| EPS (TTM) | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 66.7% | 19.2% | 24.4% | 30.2% | 14.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 35.2% | 24.5% | 22.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 29.8% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $364M | $305M | $245M | $188M | $164M | $136M | $10M | $0 | $0 | $0 | $12M | |
| Net Income TTM | $-1.28B | $-914M | $-750M | $-482M | $-435M | $-294M | $-254M | $-324M | $-193M | $-176M | $-118M | $-79M | |
| Market Cap | $37.29B | $12.38B | $4.59B | $2.71B | $3.23B | $3.42B | $2.14B | $1.01B | $2.39B | $821M | $1.12B | · | |
| Enterprise Value | $36.40B | $12.05B | $4.96B | $2.69B | $3.08B | $3.24B | $1.99B | $836M | $2.06B | $713M | $864M | · | |
| P/E | -27.1 | -12.4 | -5.8 | -5.1 | -7.0 | -11.1 | -7.9 | · | · | · | · | · | |
| P/S | 61.5 | 34.1 | 15.0 | 11.0 | 17.2 | 20.8 | 15.7 | 103.1 | · | · | · | · | |
| P/B | 50.5 | 43.4 | -13.8 | 30.8 | 7.9 | 12.4 | 8.2 | 4.9 | 6.6 | 5.3 | 3.6 | · | |
| P / Tangible Book | 73.8 | 136.7 | · | · | 16.1 | 15.1 | · | · | · | · | · | · | |
| P / Cash Flow | -39.9 | -18.1 | -8.6 | -6.8 | -8.9 | -15.6 | -8.5 | -3.9 | -15.0 | -5.6 | -11.1 | · | |
| P / FCF | -38.5 | -17.5 | -8.3 | -6.6 | -8.7 | -15.2 | -7.3 | -3.7 | -14.7 | -5.4 | -10.8 | · | |
| EV / EBITDA | -29.2 | -13.7 | -7.0 | -5.9 | -8.4 | -12.7 | -8.7 | -2.8 | -11.1 | -4.2 | -7.5 | · | |
| EV / FCF | -37.6 | -17.1 | -9.0 | -6.5 | -8.3 | -14.4 | -6.8 | -3.1 | -12.7 | -4.7 | -8.3 | · | |
| EV / Revenue | 60.0 | 33.1 | 16.3 | 11.0 | 16.4 | 19.7 | 14.6 | 85.0 | · | · | · | · | |
| Earnings Yield | -3.7% | -8.1% | -17.2% | -19.6% | -14.2% | -9.0% | -12.6% | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $425M | $306M | $264M | $142M | $107M | $93M | $104M | $93M | $90M | $76M | $84M | $79M | $77M | $65M | $59M | $68M | |
| Cost of Revenue | $67M | $47M | $44M | $29M | $28M | $21M | $26M | $21M | $21M | $17M | $18M | $17M | $17M | $14M | $13M | $13M | |
| R&D Expense | $210M | $209M | $255M | $186M | $177M | $153M | $180M | $151M | $147M | $121M | $137M | $109M | $197M | $128M | $125M | $100M | |
| SG&A Expense | $247M | $247M | $212M | $186M | $155M | $148M | $143M | $119M | $107M | $93M | $90M | $91M | $84M | $80M | $73M | $76M | |
| Operating Expenses | $427M | $459M | $584M | $508M | $420M | $341M | $335M | $307M | $379M | $221M | $262M | $227M | $313M | $213M | $211M | $195M | |
| Operating Income | $-2M | $-153M | $-320M | $-366M | $-313M | $-248M | $-230M | $-213M | $-289M | $-146M | $-178M | $-148M | $-236M | $-148M | $-151M | $-128M | |
| Interest Expense | · | · | · | · | $21M | $22M | $22M | $21M | $21M | $21M | $21M | $20M | $21M | $20M | $16M | $3M | |
| Other Non-op | $-531.0K | $-736.0K | $-2M | $-603.0K | $453.0K | $132.0K | $-445.0K | $2M | $-269.0K | $-1M | $2M | $285.0K | $-488.0K | $-111.0K | $1M | $-2M | |
| Pretax Income | $-11M | $-162M | $-327M | $-369M | $-320M | $-256M | $-234M | $-220M | $-300M | $-157M | $-185M | $-158M | $-244M | $-159M | $-160M | $-131M | |
| Income Tax | $2M | $1M | $2M | $1M | $1M | $912.0K | $1M | $1M | $838.0K | $589.0K | $998.0K | $544.0K | $530.0K | $483.0K | $125.0K | $372.0K | |
| Net Income | $-13M | $-164M | $-328M | $-370M | $-322M | $-257M | $-236M | $-221M | $-301M | $-157M | $-186M | $-159M | $-245M | $-160M | $-160M | $-131M | |
| EPS (Basic) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| EPS (Diluted) | $-0.06 | $-0.76 | $-1.55 | $-1.75 | $-1.70 | $-1.42 | $-1.30 | $-1.27 | $-1.94 | $-1.06 | $-1.28 | $-1.11 | $-1.78 | $-1.17 | $-1.22 | $-1.09 | |
| Shares (Basic) | 217,352,000 | 215,468,000 | · | 211,759,000 | 189,302,000 | 180,860,000 | · | 173,721,000 | 154,702,000 | 148,456,000 | · | 142,899,000 | 137,553,000 | 136,355,000 | · | 120,789,000 | |
| Shares (Diluted) | 217,352,000 | 215,468,000 | · | 211,759,000 | 189,302,000 | 180,860,000 | · | 173,721,000 | 154,702,000 | 148,456,000 | · | 142,899,000 | 137,553,000 | 136,355,000 | · | 120,789,000 | |
| EBITDA | $-2M | $-153M | · | $-366M | $-313M | $-248M | · | $-213M | $-289M | $-146M | · | $-148M | $-236M | $-148M | · | $-128M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $545M | $582M | $510M | $335M | $1.28B | $403M | $555M | $461M | $1.25B | $596M | · | $487M | $613M | $969M | · | $415M | |
| Short-term Investments | $616M | $641M | $920M | $1.35B | $572M | $796M | $879M | $1.01B | $0 | $0 | · | $299M | $305M | $30M | · | $99M | |
| Receivables | $215M | $179M | $141M | $65M | $55M | $48M | $52M | $42M | $40M | $37M | · | $36M | $31M | $31M | · | $27M | |
| Inventory | $142M | $133M | $132M | $121M | $108M | $101M | $99M | $98M | $90M | $83M | · | $78M | $77M | $71M | · | $66M | |
| Prepaid Expense | $116M | $78M | $91M | $66M | $62M | $55M | $37M | $41M | $41M | $43M | · | $27M | $26M | $29M | · | $25M | |
| Current Assets | $1.63B | $1.61B | $1.79B | $1.93B | $2.08B | $1.40B | $1.62B | $1.65B | $1.42B | $759M | · | $927M | $1.05B | $1.13B | · | $632M | |
| PP&E (Net) | $107M | $103M | $103M | $90M | $90M | $88M | $80M | $75M | $73M | $69M | · | $65M | $62M | $60M | · | $54M | |
| PP&E (Gross) | $174M | $166M | $164M | $147M | $145M | $141M | $130M | $124M | $120M | $115M | · | $108M | $104M | $100M | · | $92M | |
| Accum. Depreciation | $67M | $64M | $61M | $57M | $55M | $52M | $50M | $49M | $47M | $46M | · | $43M | $42M | $41M | · | $38M | |
| Goodwill | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | $136M | · | $136M | $136M | $136M | · | $136M | |
| Intangibles | $93M | $96M | $98M | $85M | $56M | $57M | $59M | $60M | $61M | $62M | $64M | $65M | $66M | $67M | · | $70M | |
| Total Assets | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Accounts Payable | $75M | $73M | $80M | $80M | $74M | $58M | $73M | $65M | $51M | $44M | · | $65M | $56M | $57M | · | $12M | |
| Current Liabilities | $439M | $361M | $469M | $417M | $312M | $239M | $298M | $259M | $524M | $421M | · | $197M | $204M | $188M | · | $138M | |
| Capital Leases | $8M | $10M | $12M | $8M | $8M | $8M | $9M | $10M | $12M | $14M | · | $13M | $13M | $15M | · | $17M | |
| Other Non-current Liabilities | $6M | $6M | $6M | $6M | $6M | $5M | $499.0K | $3M | $3M | $3M | · | $6M | $11M | $10M | · | $11M | |
| Total Liabilities | $1.35B | $1.37B | $1.53B | $1.42B | $1.23B | $1.70B | $1.74B | $1.57B | $1.77B | $1.62B | · | $1.61B | $1.59B | $1.56B | · | $1.02B | |
| Long-term Debt | $547M | $547M | $547M | $547M | $547M | $1.12B | · | $972M | $1.19B | $1.18B | · | $1.17B | $1.17B | $1.16B | · | $800M | |
| Total Debt | $544M | $542M | · | $540M | $539M | $1.11B | · | $955M | $1.17B | $1.16B | · | $1.15B | $1.14B | $1.13B | · | $785M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $6.57B | $6.50B | $6.37B | $6.25B | $6.18B | $4.71B | $4.65B | $4.61B | $3.94B | $3.14B | · | $2.97B | $2.95B | $2.81B | · | $2.51B | |
| Retained Earnings | $-5.81B | $-5.80B | $-5.64B | $-5.31B | $-4.94B | $-4.62B | $-4.36B | $-4.12B | $-3.90B | $-3.60B | · | $-3.26B | $-3.10B | $-2.86B | · | $-2.54B | |
| AOCI | $-3M | $4.0K | $1M | $2M | $2M | $-902.0K | $-2M | $547.0K | $-3M | $-2M | · | $-2M | $-1M | $1M | · | $-1M | |
| Stockholders' Equity | $757M | $705M | $739M | $946M | $1.25B | $99M | $285M | $483M | $39M | $-465M | $-332M | $-289M | $-156M | $-45M | $88M | $-30M | |
| Liabilities + Equity | $2.10B | $2.08B | $2.26B | $2.36B | $2.48B | $1.80B | $2.03B | $2.05B | $1.81B | $1.16B | · | $1.32B | $1.44B | $1.52B | · | $995M | |
| Shares Outstanding | 218,281,059 | 216,521,841 | 214,255,853 | 212,583,015 | 211,110,658 | 181,900,074 | 179,382,635 | 178,846,991 | 166,666,599 | 148,560,882 | 147,978,000 | 143,049,197 | 142,750,463 | 136,429,216 | 135,654,000 | 121,726,199 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $46M | $39M | $31M | $43M | $39M | $27M | $26M | $23M | $21M | $20M | $20M | $18M | $16M | $15M | $16M | |
| Deferred Tax | $0 | $0 | $-27.0K | $0 | $0 | $0 | $-29.0K | $0 | $0 | $0 | $-54.0K | $0 | $0 | $0 | $-231.0K | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-89M | $-223M | $-248M | $-220M | $-206M | $-262M | $-196M | $-181M | $-123M | $-184M | $-131M | $-136M | $-123M | $-146M | $-103M | $-90M | |
| CapEx | $6M | $3M | $17M | $2M | $3M | $10M | $7M | $4M | $7M | $5M | $2M | $3M | $5M | $3M | $5M | $582.0K | |
| Investing Cash Flow | $25M | $266M | $389M | $-762M | $228M | $80M | $132M | $-1.00B | $-7M | $295M | $2M | $7M | $-274M | $42M | $20M | $49M | |
| Stock Issued | · | · | $0 | $-256.0K | · | · | $-12.0K | $371M | · | · | $114M | $0 | · | · | $259M | $33M | |
| Financing Cash Flow | $27M | $30M | $34M | $33M | $858M | $29M | $159M | $397M | $781M | $3M | $123M | $1M | $44M | $-399.0K | $743M | $37M | |
| Net Change in Cash | $-37M | $72M | $176M | $-950M | $881M | $-152M | $94M | $-785M | $651M | $113M | $-5M | $-126M | $-356M | $-105M | $659M | $-1M | |
| Taxes Paid | $696.0K | $3M | $111.0K | $1M | $677.0K | $2M | $248.0K | $689.0K | $354.0K | $1M | $75.0K | $518.0K | $358.0K | $1M | $91.0K | $432.0K | |
| Free Cash Flow | · | $-226M | · | · | · | $-272M | · | · | · | $-189M | · | · | · | $-150M | · | · | |
| Levered FCF | · | · | · | · | · | $-294M | · | · | · | $-210M | · | · | · | $-170M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| Net Margin | -3.1% | -53.5% | · | -259.9% | -299.5% | -276.4% | · | -236.0% | -332.8% | -208.1% | · | -201.0% | -317.0% | -245.0% | · | -193.6% | |
| Pretax Margin | -2.7% | -53.0% | · | -259.0% | -298.3% | -275.4% | · | -235.0% | -331.8% | -207.3% | · | -200.3% | -316.3% | -244.2% | · | -193.1% | |
| EBITDA Margin | -0.36% | -50.1% | · | -257.1% | -291.3% | -267.3% | · | -228.4% | -319.8% | -192.7% | · | -186.8% | -305.0% | -227.2% | · | -188.5% | |
| ROA | -0.58% | -8.4% | · | -16.8% | -15.0% | -17.3% | · | -13.1% | -18.5% | -11.7% | · | -13.7% | -19.6% | -12.0% | · | -11.4% | |
| ROE | -1.3% | -40.7% | · | -51.8% | -49.9% | 140.3% | · | -227.3% | 514.2% | 61.7% | · | 99.6% | 439.1% | -424.7% | · | -55.2% | |
| ROIC | -0.14% | -12.4% | · | -24.7% | -17.6% | -20.7% | · | -14.9% | -23.9% | -20.9% | · | -17.3% | -24.0% | -13.7% | · | -17.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.5 | · | 4.6 | 6.7 | 5.9 | · | 6.4 | 2.7 | 1.8 | · | 4.7 | 5.2 | 6.0 | · | 4.6 | |
| Quick Ratio | 3.1 | 3.9 | · | 4.2 | 6.1 | 5.2 | · | 5.8 | 2.5 | 1.5 | · | 4.2 | 4.6 | 5.5 | · | 3.9 | |
| Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 30.2 | -2.5 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| LT Debt / Equity | 0.7 | 0.8 | · | 0.6 | 0.4 | 11.1 | · | 2.0 | 24.4 | -2.0 | · | -4.0 | -7.3 | -25.4 | · | -26.2 | |
| Interest Coverage | · | · | · | · | -14.7 | -11.5 | · | -10.1 | -13.6 | -6.9 | · | -7.3 | -11.4 | -7.4 | · | -38.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.4 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 3.1 | 2.7 | · | 2.6 | 2.3 | 2.2 | · | 2.4 | 2.5 | 2.2 | · | 2.5 | 2.6 | 2.3 | · | 2.9 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.47 | $3.26 | · | $4.45 | $5.92 | $0.55 | · | $2.70 | $0.23 | $-3.13 | · | $-2.02 | $-1.09 | $-0.33 | · | $-0.25 | |
| Revenue / Share | $1.96 | $1.42 | · | $0.67 | $0.57 | $0.51 | · | $0.54 | $0.58 | $0.51 | · | $0.55 | $0.56 | $0.48 | · | $0.56 | |
| Cash Flow / Share | · | $-1.03 | · | · | · | $-1.45 | · | · | · | $-1.24 | · | · | · | $-1.07 | · | · | |
| Cash / Share | $2.50 | $2.69 | · | $1.57 | $6.08 | $2.22 | · | $2.58 | $7.48 | $4.01 | · | $3.41 | $4.29 | $7.10 | · | $3.41 | |
| EPS (TTM) | $-4.12 | $-5.76 | · | $-6.17 | $-5.69 | $-5.93 | · | $-5.55 | $-5.39 | $-5.23 | · | $-5.28 | $-5.26 | $-4.28 | · | $-3.65 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.14B | $820M | · | $447M | $398M | $381M | · | $343M | $329M | $315M | · | $281M | $269M | $257M | · | $242M | |
| Net Income TTM | $-875M | $-1.18B | · | $-1.18B | $-1.03B | $-1.01B | · | $-864M | $-803M | $-747M | · | $-724M | $-696M | $-547M | · | $-434M | |
| Market Cap | $23.27B | $35.41B | · | $30.61B | $21.25B | $13.88B | · | $13.06B | $11.17B | $4.03B | · | $3.61B | $3.01B | $2.33B | · | $2.62B | |
| Enterprise Value | $22.66B | $34.72B | · | $29.47B | $19.93B | $13.78B | · | $12.54B | $11.09B | $4.60B | · | $3.97B | $3.23B | $2.46B | · | $2.89B | |
| P/E | -25.9 | -28.4 | · | -23.3 | -17.7 | -12.9 | · | -13.2 | -12.4 | -5.2 | · | -4.8 | -4.0 | -4.0 | · | -5.9 | |
| P/S | 20.5 | 43.2 | · | 68.5 | 53.4 | 36.4 | · | 38.1 | 34.0 | 12.8 | · | 12.9 | 11.2 | 9.0 | · | 10.8 | |
| P/B | 30.7 | 50.2 | · | 32.4 | 17.0 | 139.9 | · | 27.0 | 287.7 | -8.7 | · | -12.5 | -19.3 | -52.1 | · | -87.5 | |
| P / Tangible Book | 44.1 | 74.8 | · | 42.2 | 20.1 | · | · | 45.4 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -159.0 | · | · | · | -52.9 | · | · | · | -21.9 | · | · | · | -15.9 | · | · | |
| EV / Revenue | 19.9 | 42.4 | · | 65.9 | 50.1 | 36.2 | · | 36.6 | 33.8 | 14.6 | · | 14.2 | 12.0 | 9.6 | · | 11.9 | |
| Earnings Yield | -3.9% | -3.5% | · | -4.3% | -5.7% | -7.8% | · | -7.6% | -8.0% | -19.3% | · | -20.9% | -24.9% | -25.1% | · | -17.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $606M | $364M | $305M | $245M | $188M |
| Betriebsgewinnmarge % | -205.6% | -241.5% | -232.5% | -186.4% | -199.0% |
| Nettoergebnis | $-1.28B | $-914M | $-750M | $-482M | $-435M |
| Verwässerte EPS | $-6.42 | $-5.57 | $-5.34 | $-3.91 | $-3.88 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.7 | 3.9 | -3.5 | 12.8 | 1.4 |
| Liquiditätsgrad | 3.8 | 5.5 | 4.1 | 6.7 | 6.2 |
| Quick Ratio | 3.4 | 5.0 | 3.6 | 6.2 | 5.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-968M | $-706M | $-550M | $-410M | $-371M |
Institutionelle Eigentümer (13F) 745 Einreicher · $27.2B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
745
Gehaltener Wert
$27.2B
Neue Positionen
129
Geschlossene Positionen
115
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 129 (+11 vs. Vorquartal) | 115 (+23 vs. Vorquartal) | 256 (-28 vs. Vorquartal) | 241 (+13 vs. Vorquartal) | +7.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $3.668.126.910 | 21.076.344 | 13,48% | Aktien |
| FMR LLC | $1.721.228.828 | 16.143.583 | 6,33% | Aktien |
| BlackRock, Inc. | $1.685.447.191 | 15.807.984 | 6,19% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.109.696.908 | 10.407.962 | 4,08% | Aktien |
| JPMORGAN CHASE & CO | $1.092.246.620 | 10.428.170 | 4,01% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.043.902.026 | 9.790.865 | 3,84% | Aktien |
| BAKER BROS. ADVISORS LP | $937.841.355 | 8.796.111 | 3,45% | Aktien |
| Capital International Investors | $878.338.960 | 8.238.124 | 3,23% | Aktien |
| Darwin Global Management, Ltd. | $673.600.013 | 6.431.163 | 2,48% | Aktien |
| AMERIPRISE FINANCIAL INC | $658.878.001 | 6.179.571 | 2,42% | Aktien |
| Orbis Allan Gray Ltd | $647.875.044 | 6.076.487 | 2,38% | Aktien |
| STATE STREET CORP | $645.282.792 | 6.052.174 | 2,37% | Aktien |
| D. E. Shaw & Co., Inc. | $626.707.989 | 5.877.959 | 2,30% | Aktien |
| Artisan Partners Limited Partnership | $580.195.955 | 5.441.718 | 2,13% | Aktien |
| RTW INVESTMENTS, LP | $516.347.866 | 4.842.880 | 1,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $448.763.113 | 4.220.155 | 1,65% | Aktien |
| NORGES BANK | $360.124.083 | 3.377.641 | 1,32% | Aktien |
| UBS Group AG | $275.553.633 | 2.584.446 | 1,01% | Aktien |
| CITADEL ADVISORS LLC | $272.624.461 | 2.556.973 | 1,00% | Aktien |
| FRANKLIN RESOURCES INC | $242.371.000 | 2.273.222 | 0,89% | Aktien |
| MAVERICK CAPITAL LTD | $229.314.244 | 2.150.762 | 0,84% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $218.358.293 | 2.048.005 | 0,80% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $198.680.888 | 1.215.025 | 0,73% | Aktien |
| Qube Research & Technologies Ltd | $179.370.451 | 1.682.334 | 0,66% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $173.743.795 | 1.629.561 | 0,64% | Aktien |
| Integral Health Asset Management, LLC | $170.592.000 | 1.600.000 | 0,63% | Aktien |
| GOLDMAN SACHS GROUP INC | $150.322.007 | 1.409.885 | 0,55% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $149.433.474 | 1.401.552 | 0,55% | Aktien |
| Bellevue Group AG | $148.566.227 | 1.393.418 | 0,55% | Aktien |
| Balyasny Asset Management L.P. | $141.423.967 | 1.326.430 | 0,52% | Aktien |
| Paradigm Biocapital Advisors LP | $141.375.668 | 1.325.977 | 0,52% | Aktien |
| NORTHERN TRUST CORP | $140.239.951 | 1.315.325 | 0,52% | Aktien |
| Bank of New York Mellon Corp | $139.965.961 | 1.312.756 | 0,51% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $132.445.710 | 1.242.222 | 0,49% | Aktien |
| MORGAN STANLEY | $131.515.791 | 1.233.498 | 0,48% | Aktien |
| Pictet Asset Management Holding SA | $129.804.038 | 1.220.353 | 0,48% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $129.432.735 | 1.213.963 | 0,48% | Aktien |
| Hood River Capital Management LLC | $112.683.586 | 1.056.871 | 0,41% | Aktien |
| BANK OF AMERICA CORP /DE/ | $109.084.466 | 1.023.114 | 0,40% | Aktien |
| SEI INVESTMENTS CO | $108.312.723 | 1.015.870 | 0,40% | Aktien |
| Castle Hook Partners LP | $105.906.712 | 993.310 | 0,39% | Aktien |
| JENNISON ASSOCIATES LLC | $96.501.143 | 905.094 | 0,35% | Aktien |
| TimesSquare Capital Management, LLC | $95.626.169 | 584.798 | 0,35% | Aktien |
| Polar Capital Holdings Plc | $94.984.773 | 890.872 | 0,35% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $92.119.680 | 864.000 | 0,34% | Kaufoption |
| FIL Ltd | $91.289.537 | 856.214 | 0,34% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $91.280.154 | 856.126 | 0,34% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $90.627.000 | 850.000 | 0,33% | Aktien |
| Fiera Capital Corp | $89.885.138 | 843.042 | 0,33% | Aktien |
| Legal & General Group Plc | $88.114.072 | 826.431 | 0,32% | Aktien |
Unternehmensinsider 48 Insider · 31 Führungskräfte · 18 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| William Lewis | Chair and CEO | 23. Juli 2026 M | 259.058 | 0 | 74 | $-32.791.057 |
| Timothy Whitten | President & CEO | 1. Juni 2012 P | 10.000 | 0 | 0 | $0 |
| Geoffrey Allan | President, CEO and Chairman | 31. März 2009 M | 1.715.557 | 0 | 0 | $0 |
| Sara Bonstein | Chief Financial Officer | 3. Juni 2026 S | 69.082 | 0 | 6 | $-2.132.573 |
| Paolo Tombesi | Chief Financial Officer | 3. Januar 2019 A | 10.669 | 0 | 0 | $0 |
| Andrew T Drechsler | Chief Financial Officer | 1. März 2017 M | 15.000 | 0 | 0 | $0 |
| Kevin P Tully | Executive VP & CFO | 21. Dezember 2011 A | 377.344 | 0 | 0 | $0 |
| Steve C Glover | President Follow-on Biologics | 31. März 2009 M | 372.113 | 0 | 0 | $0 |
| Roger Adsett | Chief Operating Officer | 10. August 2026 M | 98.744 | 0 | 10 | $-48.253.225 |
| Ronald D Gunn | Executive Vice President & COO | 8. Dezember 2005 A | 40.074 | 0 | 0 | $0 |
| Martina Flammer M.D. | Chief Medical Officer | 6. August 2026 M | 60.486 | 0 | 40 | $-23.323.179 |
| Samuele Butera | SVP, GM, Global Respiratory | 23. Juni 2026 A | 7.342 | 0 | 0 | $0 |
| Michael Alexander Smith | Chief Legal Officer | 22. Juni 2026 S | 37.648 | 0 | 20 | $-13.997.738 |
| Orlov S Nicole Schaeffer | Chief People Strategy Officer | 2. Januar 2026 M | 41.754 | 0 | 9 | $-21.113.483 |
| John Drayton Wise | Chief Commercial Officer | 7. Februar 2025 S | 133.015 | 0 | 0 | $0 |
| John Soriano | Chief Compliance Officer | 7. September 2021 M | 35.204 | 0 | 0 | $0 |
| Christine A Pellizzari | Chief Legal Officer | 15. Mai 2021 F | 149.985 | 0 | 0 | $0 |
| John Goll | Chief Accounting Officer | 3. Januar 2020 A | 14.166 | 0 | 0 | $0 |
| Paul Streck | Chief Medical Officer | 8. August 2018 A | 15.996 | 0 | 0 | $0 |
| Eugene Jeffrey Sullivan | Chief Med. & Scientific Ofc. | 17. Mai 2017 A | · | 0 | 0 | $0 |
| Mark Quigley | Vice President, Quality | 12. Mai 2015 M | 0 | 0 | 0 | $0 |
| Peggy Berry | Vice President, Regulatory | 26. Februar 2015 A | · | 0 | 0 | $0 |
| Matthew Pauls | Chief Commercial Officer | 2. Juni 2014 A | · | 0 | 0 | $0 |
| Renu Gupta | Executive Vice President & CMO | 31. Januar 2014 M | 37.014 | 0 | 0 | $0 |
| Andrea Holtzman Drucker | SVP, Gen. Counsel & Corp Sec. | 3. Juni 2013 M | 45.000 | 0 | 0 | $0 |
| Nicholas A. Labella Jr. | Chief Scientific Officer | 21. Dezember 2011 A | · | 0 | 0 | $0 |
| Nicholas Lee Gurreri | Senior VP, Commercial Ops | 31. Januar 2011 A | · | 0 | 0 | $0 |
| Doug Farrar | Vice President, ITP | 31. März 2009 M | 292.055 | 0 | 0 | $0 |
| Michael Duncan | Principal Financial Officer | 8. Dezember 2005 A | · | 0 | 0 | $0 |
| Philip J Young | Chief Business Officer and EVP | 8. Dezember 2005 A | · | 0 | 0 | $0 |
| Thomas A Keuer | Sr VP, ITP (Subsidiary) | 8. Dezember 2005 A | · | 0 | 0 | $0 |
| David R Brennan | Direktor | 9. September 2026 S | 39.238 | 0 | 1 | $-3.100.000 |
| Melvin Sharoky MD | Direktor | 17. August 2026 S | 0 | 0 | 2 | $-4.737.850 |
| Clarissa Desjardins | Direktor | 13. Mai 2026 A | 70.312 | 0 | 0 | $0 |
| Elizabeth M Anderson | Direktor | 13. Mai 2026 A | 62.034 | 0 | 2 | $-2.981.600 |
| Leo Lee | Direktor | 13. Mai 2026 A | 57.971 | 0 | 5 | $-14.692.249 |
| David W J Mcgirr | Direktor | 9. Februar 2026 G | 53.400 | 0 | 0 | $0 |
| Alfred Altomari | Direktor | 13. Mai 2024 A | 69.495 | 0 | 0 | $0 |
| Steinar J Engelsen | Direktor | 1. November 2021 P | 320.802 | 0 | 0 | $0 |
| Donald J Hayden JR | Direktor | 9. April 2019 M | 62.197 | 0 | 0 | $0 |
| Myrtle S Potter | Direktor | 15. Mai 2018 A | 25.510 | 0 | 0 | $0 |
| Randall W Whitcomb | Direktor | 10. März 2015 M | 69.188 | 0 | 0 | $0 |
| Richard S Kollender | Direktor | 31. Oktober 2013 M | 24.598 | 0 | 0 | $0 |
| Dennis M Lanfear | Direktor | 9. Juni 2010 A | 168.404 | 0 | 0 | $0 |
| Graham K Crooke | Direktor | 9. Juni 2010 A | 228.404 | 0 | 0 | $0 |
| Kenneth G Condon | Direktor | 9. Juni 2010 A | 168.504 | 0 | 0 | $0 |
| FMR LLC | 10%-Eigentümer | 22. Juli 2013 S | 2.221 | 0 | 0 | $0 |
| Carol Schafer | · | 13. Mai 2026 A | 66.622 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 75 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 3,49% | 91.647 SH | 5. Oktober 2026 | Täglich |
| MEDI · Harbor ETF Trust | 2,52% | 10.513 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 2,02% | 1.640.771 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,63% | 15.602 SH | 5. Oktober 2026 | Täglich |
| SPIT · RBB Fund, Inc. | 1,60% | 5.414 NS | 31. Juli 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,39% | 13.870 NS | 31. Juli 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 1,11% | 149.372 SH | 5. Oktober 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,97% | 894 NS | 31. Juli 2026 | N-PORT |
| IWP · iShares Trust | 0,80% | 1.209.253 SH | 11. September 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,73% | 36.726 NS | 31. Juli 2026 | N-PORT |
| IYH · iShares Trust | 0,44% | 125.597 SH | 11. September 2026 | Täglich |
| IMCG · iShares Trust | 0,38% | 118.553 SH | 11. September 2026 | Täglich |
| WINN · Harbor ETF Trust | 0,36% | 40.917 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,33% | 632.581 SH | 19. August 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,32% | 1.435.651 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,30% | 100.200 NS | 31. Juli 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,26% | 15.672 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,26% | 2.487.127 SH | 19. August 2026 | Täglich |
| VOT · VANGUARD INDEX FUNDS | 0,25% | 830.249 SH | 19. August 2026 | Täglich |
| SIZE · iShares Trust | 0,23% | 7.660 SH | 11. September 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,21% | 502 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,20% | 879.778 SH | 11. September 2026 | Täglich |
| EUSA · iShares, Inc. | 0,20% | 29.864 SH | 11. September 2026 | Täglich |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0,19% | 587 NS | 31. Juli 2026 | N-PORT |
| IMCB · iShares Trust | 0,19% | 25.151 SH | 11. September 2026 | Täglich |
| FFSM · FIDELITY COVINGTON TRUST | 0,19% | 28.857 NS | 31. Juli 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 38.663 NS | 31. Juli 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,14% | 2.485.842 SH | 19. August 2026 | Täglich |
| ESLG · Strategy Shares | 0,13% | 313 NS | 31. Juli 2026 | N-PORT |
| ESUM · Strategy Shares | 0,13% | 2.410 NS | 31. Juli 2026 | N-PORT |
| LRND · New York Life Investments ETF Trust | 0,12% | 4.894 NS | 31. Juli 2026 | N-PORT |
| ESLV · Strategy Shares | 0,12% | 171 NS | 31. Juli 2026 | N-PORT |
| SUSA · iShares Trust | 0,11% | 35.904 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 27.364 SH | 5. Oktober 2026 | Täglich |
| VO · VANGUARD INDEX FUNDS | 0,11% | 2.348.570 SH | 19. August 2026 | Täglich |
| USXF · iShares Trust | 0,11% | 12.482 SH | 11. September 2026 | Täglich |
| SDG · iShares Trust | 0,10% | 1.340 SH | 11. September 2026 | Täglich |
| ESSC · Strategy Shares | 0,10% | 368 NS | 31. Juli 2026 | N-PORT |
| ILCG · iShares Trust | 0,09% | 20.984 SH | 10. September 2026 | Täglich |
| IWF · iShares Trust | 0,08% | 806.337 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,08% | 5.939 SH | 5. Oktober 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,08% | 53.285 NS | 31. Juli 2026 | N-PORT |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,07% | 339.999 SH | 19. August 2026 | Täglich |
| VUG · VANGUARD INDEX FUNDS | 0,05% | 1.801.856 SH | 19. August 2026 | Täglich |
| DYNF · BlackRock ETF Trust | 0,05% | 147.228 SH | 11. September 2026 | Täglich |
| ILCB · iShares Trust | 0,04% | 4.085 SH | 11. September 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,04% | 7.753 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,04% | 48.501 SH | 19. August 2026 | Täglich |
| IWB · iShares Trust | 0,04% | 148.337 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,04% | 9.185 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,04% | 283.947 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,04% | 59.481 SH | 11. September 2026 | Täglich |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,04% | 34.123 SH | 5. Oktober 2026 | Täglich |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 29.520 NS | 31. Juli 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,03% | 3.623 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,03% | 17.548 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,03% | 66.777 NS | 31. Juli 2026 | N-PORT |
| TOK · iShares Trust | 0,03% | 583 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,03% | 6.885.800 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,03% | 35.614 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,03% | 18.072 SH | 19. August 2026 | Täglich |
| TOV · EA Series Trust | 0,03% | 751 NS | 31. Juli 2026 | N-PORT |
| URTH · iShares, Inc. | 0,03% | 18.868 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,03% | 17.415 NS | 31. Juli 2026 | N-PORT |
| ACWI · iShares Trust | 0,03% | 67.041 SH | 11. September 2026 | Täglich |
| CRBN · iShares Trust | 0,02% | 2.066 SH | 11. September 2026 | Täglich |
| VV · VANGUARD INDEX FUNDS | 0,02% | 126.924 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,02% | 178.900 SH | 19. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,02% | 4.108 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 4.167 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 5.993 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 18.487 NS | 31. Juli 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,01% | 250 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 48.566 NS | 31. Juli 2026 | N-PORT |
| SMLF · iShares Trust | · | 124.879 SH | 11. September 2026 | Täglich |
INSM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 30 Analysten
KAUF
Median-Ziel
$195.00
+85,3%
9 30,0%
Starker Kauf
20 66,7%
Kauf
1 3,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
23 Analysten · 2026-10-06Mittelwert-Ziel $197.74 +87,9%
← Unter allen Zielen
Aktueller Preis $105.23
Tief$169.00
Mittelwert$197.74
Hoch$243.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | · |
| RVMD | · | · | · | · | · | · |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | · |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | · |
| UTHR | $21.27B | 17.5 | 10.6% | 41.9% | 18.7% | 87.9% |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | · |
| NBIX | $14.20B | 30.4 | 21.4% | 16.7% | 16.1% | · |
| EXEL | $11.44B | 15.7 | 7.0% | 33.7% | 37.3% | · |
| SMMT | $13.56B | -12.1 | · | · | -235.1% | · |
| BBIO | $14.90B | -20.2 | 126.3% | -146.0% | 41.2% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Is Insmed (INSM) One of the Most Promising Healthcare Stocks After Cantor Fitzgerald’s Target Raise?
Yahoo Finance · 3 Monate, 2 Wochen vor
Wettbewerbsdruck veranlasst Truist, Kursziel für Insmed (INSM) zu senken
Yahoo Finance · 4 Monate, 2 Wochen vor
Insmed CEO enthüllt, dass die Patientenzahl in Japan den US-Markt für Lungenerkrankungen übersteigt
Yahoo Finance · 6 Monate, 1 Woche vor
Artisan Small Cap Fund Verkauft Insmed (INSM) aufgrund von Bewertungsüberlegungen
Yahoo Finance · 6 Monate, 2 Wochen vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026